Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04176081
Title Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer (SChLAP/IDC)
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Age Groups: senior | adult
Covered Countries CAN

No variant requirements are available.